Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database
Natural History and Long Term Clinical Assessments of All Forms of Neuronal Ceroid Lipofuscinoses - Capturing Key Symptoms and Disease Progression as Part of the Independent, International NCL DEM-CHILD Patient Database
Universitätsklinikum Hamburg-Eppendorf
500 participants
Apr 8, 2020
OBSERVATIONAL
Conditions
Summary
This is an observational study that aims at assessing the natural history of NCL diseases as part of the international DEM-CHILD Database. 1. Patient data are collected from medical records, patient questionnaires and routine follow up clinical examinations with focus on assessing progression in key areas of disease such as motor, language, cognition, seizures, vision, and behavior. 2. A local biorepository of samples from genetically defined NCL patients will be established as well as a virtual biorepository within the DEM-CHILD DB to be able to easily localize international availability of patient samples.
Eligibility
Inclusion Criteria4
- \- Patients with a confirmed molecular diagnosis of a form of NCL Disease
- Documented diagnosis of TPP1 deficiency
- Previous or current treatment with intracerebroventricular ERT with cerliponase alpha
- Patients that are currently participating in post-marketing studies will be allowed to participate.
Exclusion Criteria1
- \- Patients with no confirmed molecular diagnosis of a form of NCL Disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Natural History and Clinical Follow Up.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04613089